MESO
Price
$14.39
Change
+$0.87 (+6.43%)
Updated
Sep 5 closing price
Capitalization
1.77B
79 days until earnings call
QTTB
Price
$1.67
Change
+$0.01 (+0.60%)
Updated
Sep 5 closing price
Capitalization
20.37M
Interact to see
Advertisement

MESO vs QTTB

Header iconMESO vs QTTB Comparison
Open Charts MESO vs QTTBBanner chart's image
Mesoblast
Price$14.39
Change+$0.87 (+6.43%)
Volume$379.26K
Capitalization1.77B
Q32 Bio
Price$1.67
Change+$0.01 (+0.60%)
Volume$74.31K
Capitalization20.37M
MESO vs QTTB Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. QTTB commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and QTTB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (MESO: $14.39 vs. QTTB: $1.67)
Brand notoriety: MESO and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 185% vs. QTTB: 4%
Market capitalization -- MESO: $1.77B vs. QTTB: $20.37M
MESO [@Biotechnology] is valued at $1.77B. QTTB’s [@Biotechnology] market capitalization is $20.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, both MESO and QTTB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 7 TA indicator(s) are bullish while QTTB’s TA Score has 3 bullish TA indicator(s).

  • MESO’s TA Score: 7 bullish, 3 bearish.
  • QTTB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MESO is a better buy in the short-term than QTTB.

Price Growth

MESO (@Biotechnology) experienced а +4.05% price change this week, while QTTB (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

MESO is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($1.77B) has a higher market cap than QTTB($20.4M). MESO YTD gains are higher at: -27.323 vs. QTTB (-51.453). QTTB has higher annual earnings (EBITDA): -33.17M vs. MESO (-77.78M). QTTB has more cash in the bank: 54.8M vs. MESO (37.7M). QTTB has less debt than MESO: QTTB (18.7M) vs MESO (126M). MESO has higher revenues than QTTB: MESO (5.67M) vs QTTB (0).
MESOQTTBMESO / QTTB
Capitalization1.77B20.4M8,681%
EBITDA-77.78M-33.17M234%
Gain YTD-27.323-51.45353%
P/E RatioN/AN/A-
Revenue5.67M0-
Total Cash37.7M54.8M69%
Total Debt126M18.7M674%
FUNDAMENTALS RATINGS
MESO vs QTTB: Fundamental Ratings
MESO
QTTB
OUTLOOK RATING
1..100
7818
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4390
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (39) in the null industry is somewhat better than the same rating for MESO (87) in the Biotechnology industry. This means that QTTB’s stock grew somewhat faster than MESO’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as MESO (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to MESO’s over the last 12 months.

MESO's SMR Rating (96) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

MESO's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for QTTB (90) in the null industry. This means that MESO’s stock grew somewhat faster than QTTB’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESOQTTB
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFSVX14.830.13
+0.88%
iMGP Small Company Fund Instl Cl
WFMIX51.320.13
+0.25%
Allspring Special Mid Cap Value Inst
FSCVX27.23-0.02
-0.07%
Nuveen Small Cap Value C
REVRX13.80-0.06
-0.43%
Columbia Global Value R
TRNEX41.25-0.19
-0.46%
T. Rowe Price New Era I

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+6.43%
QTTB - MESO
51%
Loosely correlated
+0.60%
SLGL - MESO
37%
Loosely correlated
-0.14%
AVTX - MESO
32%
Poorly correlated
+14.17%
ZURA - MESO
30%
Poorly correlated
+6.28%
TRAW - MESO
28%
Poorly correlated
+7.51%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
+0.60%
CLRB - QTTB
65%
Loosely correlated
N/A
MESO - QTTB
51%
Loosely correlated
+6.43%
STOK - QTTB
49%
Loosely correlated
+5.35%
ADCT - QTTB
46%
Loosely correlated
+4.12%
ANAB - QTTB
39%
Loosely correlated
+3.84%
More